Oligonucleotide Synthesis Market Therapeutic Assessment 2019 by Product Type-synthesized oligonucleotides, reagents and equipment, by Application-diagnostic, genetic testing, research, therapeutics, gene synthesis, by End User-academic research institutes, diagnostic laboratories, pharmaceutical - Forecast till 2022
— Oligonucleotide Synthesis Market Overview
The global oligonucleotide synthesis market is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report. The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and global prevalence of chronic diseases spurring the demand for better medicines.
Advancing technologies have substantially raised the hope for better treatment in the healthcare sector. One of the chief driving forces is biotechnology which is constantly updating itself and impacting the former sector. Of the many ensuing projects, oligonucleotide synthesis is an evolving technique that forms inexpensive, custom-made oligonucleotides with the desired sequence. Its importance lies in its contribution in DNA or RNA synthesizing and hybridization and in the synthesis of artificial genes.
Get Free sample Copy at https://www.marketresearchfuture.com/sample_request/2337
However, the cost can prove to be a great market deterrent. The oligonucleotide synthesis requires expert hands, and its research and development process can incur high expenditure which can impede the growth in the near future. But it has the potential to counter chronic diseases by developing suitable drugs which can create a favorable ambiance for the market.
The global oligonucleotide synthesis market can be segmented by product type, application, and end-users.
Based on product type, the market can be segmented into synthesized oligonucleotides, reagents and equipment.
Application-wise segmentation of the market includes diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others.
Based on end-users, the market comprises academic research institutes, diagnostic laboratories, and pharmaceutical & biotechnology companies.
Region-specific segmentation of the market includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
North America has the largest market for oligonucleotide synthesis. The region invests in research and development substantially, and it has a superlative infrastructure in biotechnology sector which is triggering further market growth. In addition, the healthcare sector, with an eye searching constantly for new treatments for chronic diseases such as cancer and diabetes, is taking the market forward. Governments and private investors are also funding researches as they are equally eager to get positive results.
Europe is also fetching in substantial revenue as the region has almost similar kind of ambiance like North America for advanced researches. And its position has further been solidified by the presence of big league market players. The APAC region is showing lots of promises as emerging economies such as India and China are investing heavily in biotechnological researches and developments which is directly expanding the scope for oligonucleotide synthesis market growth. Governments in this region are also supporting the market considerably by approving funds.
Brows Complete Premium Research at https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337
The competitive market is witnessing several strategies being implemented by market behemoths. For instance, Danaher’s taking over of Integrated DNA Technologies can be seen as an effort to enhance the market portfolio. LGC is following the same suit by acquiring BioAutomation Corporation, the latter a manufacturer of the renowned MerMade oligo synthesis instruments. On the other hand, STA Pharmaceuticals has signed a collaboration with Regulus to establish high-quality oligonucleotide research and development center.
Some of the key players in this market are Integrated DNA Technologies, Inc (U.S), GE Healthcare (U.S.), Agilent Technologies Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Bioautomation Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), and Nitto Denko Avecia Inc. (Japan) and others.
TABLE OF CONTENTS
1... Report Prologue
2... Market Introduction
3... Research Methodology
4... Market Dynamics
5... Market Factor Analysis
5.1 Value/Supply Chain Analysis
5.2 Porter's 5 Forces Analysis
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
6... Global Oligonucleotide Pool Library Market, By Types (USD Million)
6.2 Historical Market Growth
6.3 Y-O-Y Growth Projections By Types
6.4 Market Size By Types
6.4.1 DNA Pool
6.4.2 RNA Pool
Ask for any Query at https://www.marketresearchfuture.com/enquiry/2337
7... Global Oligonucleotide Pool Library Market, By Methods (USD Million)
7.2 Historical Market Growth
Name: Mr. Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune
Phone: +1 646 845 9312
Release ID: 492506